Abstract:Background: There has been a global decrease in seasonal influenza activity since the onset of the COVID-19 pandemic. Objective: We aimed to describe influenza activity during the 2021/2022 season and compare it to the trends from 2012 to 2023. We also explored the influence of social and public health prevention measures during the COVID-19 pandemic on influenza activity. Methods: We obtained influenza data from January 1, 2012, to February 5, 2023, from publicly available platforms for China, the United States, and Australia. Mitigation measures were evaluated per the stringency index, a composite index with 9 measures. A general additive model was used to assess the stringency index and the influenza positivity rate correlation, and the deviance explained was calculated. Results: We used over 200,000 influenza surveillance data. Influenza activity remained low in the United States and Australia during the 2021/2022 season. However, it increased in the United States with a positive rate of 26.2% in the 49th week of 2022. During the 2021/2022 season, influenza activity significantly increased compared with the previous year in southern and northern China, with peak positivity rates of 28.1% and 35.1% in the second week of 2022, respectively. After the COVID-19 pandemic, the dominant influenza virus genotype in China was type B/Victoria, during the 2021/2022 season, and accounted for >98% (24,541/24,908 in the South and 20,543/20,634 in the North) of all cases. Influenza virus type B/Yamagata was not detected in all these areas after the COVID-19 pandemic. Several measures individually significantly influence local influenza activity, except for influenza type B in Australia. When combined with all the measures, the deviance explained values for influenza A and B were 87.4% (P<.05 for measures of close public transport and restrictions on international travel) and 77.6% in southern China and 83.4% (P<.05 for measures of school closing and close public transport) and 81.4% in northern China, respectively. In the United States, the association was relatively stronger, with deviance-explained values of 98.6% for influenza A and 99.1% (P<.05 for measures of restrictions on international travel and public information campaign) for influenza B. There were no discernible effects on influenza B activity in Australia between 2020 and 2022 due to the incredibly low positive rate of influenza B. Additionally, the deviance explained values were 95.8% (P<.05 for measures of restrictions on gathering size and restrictions on international travel) for influenza A and 72.7% for influenza B. Conclusions: Influenza activity has increased gradually since 2021. Mitigation measures for COVID-19 showed correlations with influenza activity, mainly driven by the early stage of the pandemic. During late 2021 and 2022, the influence of mitigation management for COVID-19 seemingly decreased gradually, as the activity of influenza increased compared to the 2020/2021 season.

Changes in Influenza Activity and Circulating Subtypes During the COVID-19 Outbreak in China

Influenza activity during the outbreak of coronavirus disease 2019 in Chinese mainland

Global variability of influenza activity and virus subtype circulation from 2011 to 2023

Changes in the Epidemiological Features of Influenza After the COVID-19 Pandemic in China, the United States, and Australia: Updated Surveillance Data for Influenza Activity

Change from Low to Out-of-season Epidemics of Influenza in China During the COVID-19 Pandemic: A Time Series Study.

[Epidemic trends and prevention and control of seasonal influenza in China after the COVID-19 pandemic]

Impact of COVID-19 Prevention and Control on the Influenza Epidemic in China: A Time Series Study

Impact of COVID-19 outbreaks and interventions on influenza in China and the United States

Clinical characteristics and outcomes during a severe influenza season in China during 2017-2018.

Molecular epidemiology and phylogenetic analysis of influenza viruses A (H3N2) and B/Victoria during the COVID-19 pandemic in Guangdong, China

From Outbreak to Near Disappearance: How Did Non-pharmaceutical Interventions Against COVID-19 Affect the Transmission of Influenza Virus?

Seroprevalence of Influenza Viruses in Shandong, Northern China During the COVID-19 Pandemic

The effect of nonpharmaceutical interventions on influenza virus transmission

Impact of China's COVID-19 Prevention and Control Efforts on Outbreaks of Influenza.

Influenza?s Plummeting During the COVID-19 Pandemic: the Roles of Mask-Wearing, Mobility Change, and SARS-CoV-2 Interference

An intense out-of-season rebound of the influenza activity after the relaxation of COVID-19 restrictions in Beijing, China

An Intense Out-of-Season Rebound of Influenza Activity after the Relaxation of Coronavirus Disease 2019 Restrictions in Beijing, China.

Molecular epidemiology and vaccine compatibility analysis of seasonal influenza A viruses in the context of COVID‐19 epidemic in Wuhan, China

Decreased Incidence of Influenza During the COVID-19 Pandemic

The Incoming Influenza Season — China, the United Kingdom, and the United States, 2021–2022

Increased population susceptibility to seasonal influenza during the COVID‐19 pandemic in China and the United States